BIOPREMIER CLINICAL develops new tests for the detection of pathogenic microorganisms and infectious diseases. Presently, the company is developing several new tests for lower tract respiratory infectious diseases. This pathology is one of the most difficult to correctly diagnose, and the rate of a successful diagnostic is achieved only in about 50% of the cases.

Biopremier was granted with several R&D projects, whether individually or in collaboration with other companies and hospitals, which allow the company to proceed to a faster development of the new tests.

BIOPREMIER facilities are composed by brand new laboratories that were built to ensure high levels of quality and safety. Depending on the methodologies and biological material, the laboratory activities are performed in separated rooms that enable a unidirectional step-forward route of the biological samples.